These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3548951)

  • 1. The role of L-dopa holiday in the long-term management of Parkinson's disease.
    Kaye JA; Feldman RG
    Clin Neuropharmacol; 1986; 9(1):1-13. PubMed ID: 3548951
    [No Abstract]   [Full Text] [Related]  

  • 2. Parkinson's disease: follow-up after "drug holiday".
    Feldman RG; Kaye JA; Lannon MC
    J Clin Pharmacol; 1986; 26(8):662-7. PubMed ID: 3793959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The results of drug holiday in Parkinson's disease].
    Martínez F; Castillo J; Castro A; Lema M; Noya M
    Neurologia; 1992 Nov; 7(9):254-9. PubMed ID: 1445710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of the "drug holiday" on problems of long-term levodopa therapy against Parkinson's disease].
    Mizuno Y; Joshita Y; Yoshida M; Kaneko J; Tanaka Y; Nagatsuka Y
    Nihon Naika Gakkai Zasshi; 1984 Apr; 73(4):474-80. PubMed ID: 6470552
    [No Abstract]   [Full Text] [Related]  

  • 5. Mavoglurant (AFQ056) in combination with increased levodopa dosages in Parkinson's disease patients.
    Kumar R; Hauser RA; Mostillo J; Dronamraju N; Graf A; Merschhemke M; Kenney C
    Int J Neurosci; 2016; 126(1):20-4. PubMed ID: 24007304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is L-DOPA drug holiday useful?
    Direnfeld LK; Feldman RG; Alexander MP; Kelly-Hayes M
    Neurology; 1980 Jul; 30(7 Pt 1):785-8. PubMed ID: 7190248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reappraisal of temporary levodopa withdrawal ("drug holiday") in Parkinson's disease.
    Mayeux R; Stern Y; Mulvey K; Cote L
    N Engl J Med; 1985 Sep; 313(12):724-8. PubMed ID: 4033697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Improved therapeutic response to L-dopa in Parkinson's disease, when combined with bromocriptine (author's transl)].
    Ulm G
    Nervenarzt; 1981 Feb; 52(2):116-20. PubMed ID: 7219619
    [No Abstract]   [Full Text] [Related]  

  • 9. Patterns of clinical response and plasma dopa levels in Parkinson's disease.
    Tolosa ES; Martin WE; Cohen HP; Jacobson RL
    Neurology; 1975 Feb; 25(2):177-83. PubMed ID: 1167646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Drug holiday" in Parkinson's disease.
    Kenny A; Murrin LC; Pfeiffer RF
    Nebr Med J; 1987 May; 72(5):149-53. PubMed ID: 3587443
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term levodopa in Parkinson's disease.
    Yahr MD
    Lancet; 1977 Mar; 1(8013):706-7. PubMed ID: 66509
    [No Abstract]   [Full Text] [Related]  

  • 12. A longitudinal study of the effects of an L-dopa drug holiday on the course of Parkinson's disease.
    Corona T; Rivera C; Otero E; Stopp L
    Clin Neuropharmacol; 1995 Aug; 18(4):325-32. PubMed ID: 8665545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of Parkinson's disease with levodopa and a dopa decarboxylase inhibitor].
    Londoõ R
    Neurol Neurocir Psiquiatr; 1976; 17(4):293-300. PubMed ID: 1018729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary factors in the management of Parkinson's disease.
    Kempster PA; Wahlqvist ML
    Nutr Rev; 1994 Feb; 52(2 Pt 1):51-8. PubMed ID: 8183469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-dopa plus dopa-decarboxylase inhibitor. Sleep organization in Parkinson's syndrome before and after treatment.
    Bergonzi P; Chiurulla C; Gambi D; Mennuni G; Pinto F
    Acta Neurol Belg; 1975; 75(1):5-10. PubMed ID: 1202895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of relationships between L-dopa plasma levels and therapeutic effect in Parkinson's disease treated with L-dopa.
    Algeri S; Ruggieri S; Miranda F; Casacchia M; Morselli PL; Agnoli A
    Eur Neurol; 1976; 14(3):219-28. PubMed ID: 1278194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enteric-coated L-dopa (prodopa). A new approach to L-dopa therapy in Parkinson's disease.
    Gilligan B; Hancock R
    Med J Aust; 1975 Nov; 2(22):824-6. PubMed ID: 1207582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of Parkinson's syndrome with a combination of levodopa and carbidopa].
    Lombardo L; De la Garza R
    Arch Invest Med (Mex); 1977; 8(2):123-8. PubMed ID: 907417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switching L-dopa Therapy from Pulsatile to Pulse Administration Reduces Motor Complications in Parkinson's Disease.
    Mostile G; Nicoletti A; Dibilio V; Luca A; Raciti L; Sciacca G; Cicero CE; Vasta R; Donzuso G; Contrafatto D; Zappia M
    Clin Neuropharmacol; 2017; 40(1):6-10. PubMed ID: 27879548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nighttime levodopa infusions to treat motor fluctuations in advanced Parkinson's disease: preliminary observations.
    Sage JI; Mark MH
    Ann Neurol; 1991 Oct; 30(4):616-7. PubMed ID: 1789688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.